Stockscreener 앱 받기
68.67
1.84%
-1.29
전일 마감가:
$69.96
열려 있는:
$69.84
하루 거래량:
3.48M
Relative Volume:
1.85
시가총액:
$10.70B
수익:
$1.17B
순이익/손실:
$150.71M
주가수익비율:
73.05
EPS:
0.94
순현금흐름:
$245.03M
1주 성능:
+4.52%
1개월 성능:
+19.55%
6개월 성능:
+32.59%
1년 성능:
-9.76%
1일 변동 폭
$68.21
$70.30
1주일 범위
$63.91
$70.66
52주 변동 폭
$46.01
$79.28
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
612-379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
TECH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
68.67 | 10.90B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
Bio-Techne Corp $TECH Shares Bought by Stephens Investment Management Group LLC - MarketBeat
Pembroke Management LTD Purchases 37,189 Shares of Bio-Techne Corp $TECH - MarketBeat
R&D Systems™ Luminex® Portfolio - Select Science
Here's what to expect from Bio-Techne's next earnings report - MSN
Bio-Techne Corp (TECH) Stock Analysis: Potential Upside and Analyst Confidence in the Biotech Arena - DirectorsTalk Interviews
Summit Creek Advisors LLC Sells 16,450 Shares of Bio-Techne Corp $TECH - MarketBeat
Conestoga Capital Advisors LLC Reduces Stake in Bio-Techne Corp $TECH - MarketBeat
HB Wealth Management LLC Sells 15,466 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
(TECH) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Here's What to Expect From Bio-Techne's Next Earnings Report - Yahoo Finance
StreetInsider.comHere's What to Expect From Bio-Techne's Next Earnings Report - FinancialContent
A Look At Bio-Techne (TECH) Valuation After Analyst Downgrade And Softer Cash Flow Concerns - Yahoo Finance
Bio-Techne Corp. stock outperforms competitors on strong trading day - MSN
What technical signals suggest for Bio Techne Corporation stock - ulpravda.ru
What makes Bio Techne Corporation (TE1) stock appealing to growth investorsJuly 2025 News Drivers & Scalable Portfolio Growth Methods - Улправда
How Bio Techne Corporation (TE1) stock reacts to stronger dollar2025 Retail Activity & Safe Entry Momentum Tips - Улправда
Rep. April McClain Delaney Purchases Shares of Bio-Techne Corp (NASDAQ:TECH) - MarketBeat
Bio-Techne (NASDAQ:TECH) Stock Acquired Rep. April McClain Delaney - MarketBeat
Maryland Representative April McClain Delaney Purchased as Much as $135,000 in Bio-Techne Shares - Bitget
Bio-Techne (NASDAQ:TECH) Cut to Hold at Evercore ISI - MarketBeat
Evercore ISI Group downgrades Bio-Techne (TECH) - MSN
TECH: Evercore ISI Downgrades Bio-Techne's Rating and Lowers Pri - GuruFocus
3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Finviz
Should Bio-Techne’s (TECH) Revenue Miss Raise Doubts About Its Scientific Platform’s Commercial Potential? - simplywall.st
Bio-Techne Corp (NASDAQ:TECH) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Fort Washington Investment Advisors Inc. OH Buys 35,165 Shares of Bio-Techne Corp $TECH - MarketBeat
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) - Yahoo Finance
Bio-Techne Corp (TECH): Stock Analysis Reveals A 17.64% Potential Upside For Investors - DirectorsTalk Interviews
Bio-Techne Corp (TECH) Stock Price History & Data - Traders Union
Voya Investment Management LLC Has $7.04 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Assenagon Asset Management S.A. Invests $2.75 Million in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference - Investing News Network
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return - Yahoo Finance
Bio-Techne Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Riverbridge Partners LLC Trims Stock Position in Bio-Techne Corp $TECH - MarketBeat
Will Bio Techne Corporation stock gain from strong economyMarket Rally & Free Low Drawdown Momentum Trade Ideas - Улправда
Why Bio Techne Corporation stock appeals to analystsJuly 2025 Momentum & Capital Protection Trade Alerts - Улправда
Will New 3D Multiomic Workflow and Leo System Expansion Change Bio-Techne's (TECH) Narrative? - simplywall.st
How Bio Techne Corporation stock compares to industry benchmarksJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - DonanımHaber
Bio-Techne (NASDAQ:TECH) Downgraded to Strong Sell Rating by Zacks Research - MarketBeat
Trading Action: Will Bio Techne Corporation stock gain from strong economyMarket Volume Summary & Technical Pattern Based Buy Signals - Улправда
Thrivent Financial for Lutherans Has $11.53 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Corient Private Wealth LLC Reduces Stake in Bio-Techne Corp $TECH - MarketBeat
Aaron Wealth Advisors LLC Takes $980,000 Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector? - Barchart.com
Neuberger Berman Group LLC Has $128.62 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Reassessing Bio-Techne (TECH) Valuation After a Weak Year and Recent Share Price Rebound - simplywall.st
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
바이오-테크네 주식 (TECH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Geist William | PRESIDENT, PROTEIN SCIENCES |
Nov 03 '25 |
Option Exercise |
0.00 |
9,911 |
0 |
25,023 |
| Nusse Roeland | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,599 |
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
4.73%
0.92%
자본화:
|
볼륨(24시간):